Manjit K. Singh
University of Rochester
8 Papers
4 Citations
Manjit K. Singh is an academic researcher from University of Rochester. The author has contributed to research in topics: Medicine & Clinical study design. The author has an hindex of 6, co-authored 8 publications. Previous affiliations of Manjit K. Singh include University of California, San Francisco & University of California, Los Angeles.
Chat about Author
Papers
2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
Dinesh Khanna,John FitzGerald,Puja P. Khanna,Sangmee Bae,Manjit K. Singh,Tuhina Neogi,Michael H. Pillinger,Joan Merill,Susan J. Lee,Shraddha Prakash,Marian Kaldas,Maneesh Gogia,Fernando Perez-Ruiz,William J. Taylor,Frédéric Lioté,Hyon K. Choi,Jasvinder A. Singh,Nicola Dalbeth,Sanford Kaplan,Vandana Dua Niyyar,Danielle Jones,Steven A. Yarows,Blake J. Roessler,Gail S. Kerr,Charles H. King,Gerald Levy,Daniel E. Furst,N. Lawrence Edwards,Brian F. Mandell,H. Ralph Schumacher,Mark L. Robbins,Neil S. Wenger,Robert Terkeltaub +32 more
TL;DR: DINESH KHanNA, JOHN D. FITZGERALD, PUJA P. KHANNA, SANGMEE BAE, MANJIT K. SINGH, TUHINA NEOGI, MICHAEL H. PILLINGER, JOAN MERILL, SUSAN LEE, SHRADDHA PRAKASH, MARIAN KALDAS, MANEESH GOGIA, FERNANDO PEREZ-RUI
Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis.
Karen Au,Manjit K. Singh,Vijay Bodukam,Sangmee Bae,Paul Maranian,Rikke Ogawa,Brennan Spiegel,Maureen McMahon,Bevra H. Hahn,Dinesh Khanna +9 more
TL;DR: Patients with SSc have an increased risk of atherosclerosis compared to healthy subjects, and marked heterogeneity between studies was mainly attributable to variations in disease duration and differences in the mean/median age between SSc patients and controls.
194
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
Dinesh Khanna,Daniel E. Furst,Yannick Allanore,Sangmee Bae,Vijay Bodukam,Philip J. Clements,Maurizio Cutolo,László Czirják,Christopher P. Denton,Oliver Distler,Ulrich A. Walker,Marco Matucci-Cerinic,Ulf Müller-Ladner,James R. Seibold,Manjit K. Singh,Alan Tyndall +15 more
TL;DR: A general outline for PTCs for controlled clinical trials in SSc was developed using European League Against Rheumatism suggestions and should lead to more uniform and higher-quality trials and clearly delineate areas where further research is needed.
39
Work productivity in scleroderma: analysis from the University of California, Los Angeles scleroderma quality of life study
TL;DR: To examine the productivity of patients with scleroderma (systemic sclerosis [SSc] both outside of and within the home in a large observational cohort.
33